by The global biotechnology market is projected to grow at a CAGR of nearly 8.7% between 2021 and 2030 and is projected to reach 1,683.52 billion by 2030.
The study provides an analysis of the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2021 is considered as the base year.
Biotechnology is an interdisciplinary field that uses living creatures, biological systems, or derivatives to improve or develop procedures and outcomes for the production of healthcare products and therapies. It has a significant impact on a variety of industries, including medical and pharmaceuticals, genomics, and food and chemical manufacturing. It can be used to address a wide range of issues, including health and well-being, food and energy security, and environmental protection.
Get a Free Sample Copy of this Report@ https://www.precedenceresearch.com/sample/1450
The continuous advancements in molecular biology have resulted in the emergence of new scientific disciplines such as genomics and proteomics. The development of therapeutics and other medications has been aided by the need for medication discovery and development has grown as the prevalence of chronic diseases has increased. Due to broad nature of application, it is being employed more frequently in various industrial areas. The increasing use of organic products in agriculture is also contributing to the market expansion.
Table of Contents
Scope of the Biotechnology Market
| Report Coverage | Details |
| Market Size in 2020 | USD 733.5 Billion |
| Growth Rate From 20201 to 2030 | CAGR of 8.7% |
| Revenue Projection by 2030 | USD 1,683.52 Billion |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Application, Technology, Region |
Biotechnology Market Report Highlights
- Based on the application, the bio-pharmacy segment dominated the global biotechnology market in 2020 with highest market share. The desire to avoid negative effects of some small-molecule medicines and invasive surgical treatments is driving up demand for bio-pharmacy.
- Based on the technology, the nanobiotechnologysegment is estimated to be the most opportunistic segment during the forecast period. Due to increase in the number of new and innovative products currently ongoing clinical trials, the nanobiotechnology segment is expected to grow at a rapid pace.
Market Dynamics:
Drivers
Growing incidence of chronic diseases
The rate of chronic diseases has increased over a period of time. The bio-pharmacy segment is contributing towards the prevention of chronic diseases. The bio-pharmacy companies are focusing on improving individualized treatments. This will aid in the treatment of certain inherited genetic illnesses and open the way for the development of personalized procedural healthcare requirements. In addition, the new concepts are being introduced into the market, such as cell therapy for certain cancer treatments, which has the potential to deliver treatment of diseases effectively. Thus, the growing incidences of chronic diseases are driving the growth of biotechnology market during the forecast period.
Restraints
High equipment costs
With the advancements of biotechnologies, there is a growing demand for easy-to-use bioinformatics tools. Bioinformaticians do not make up the majority of experimental researchers. As a result, user-friendly tools are essential for bioinformatics platform utilization. Because they lack a proper user-friendly interface, many bioinformatics applications necessitate significant computer knowledge. The utilization and implementation of biotechnology equipment require huge amount of capital. Thus, the high equipment costs are hindering the growth of biotechnology market during the forecast period.
Opportunities
Technological advancements
By utilizing innovative technologies, growing developments in life sciences are providing several benefits related with healthcare treatments and productivity. The development of innovative techniques and their deployment by businesses has a beneficial impact on the biotechnology market and is expected to promote significant market growth. In medical, cutting-edge technology are used to generate certain components of the human body. By offering exact models for study and analysis, the ability to produce human cells and tissues would broaden the spectrum of applications in medical research. Thus, the technological advancements is creating lucrative opportunities for the growth of the biotechnology market.
Read Also: Power Rental Market Size to Hit US$ 26.02 Bn by 2030
Challenges
Patient data confidentiality concerns
The increase in number of chronic diseases has led to increase in number of patients. The bio-informatics helps to store data of patients on a large scale. All this information is stored in next-generation sequencing technology. As a lot of information is still untapped, data analysis is required. As a result, the data left behind from bioinformatics analysis is extremely valuable and can be reused. The problems of data management in bioinformatics are not effectively addressed by current technologies. Thus, the patient data confidentiality is a biggest challenge for the growth of biotechnology market during the forecast period.
Regional Snapshot
North America is the largest segment for biotechnology market in terms of region. The biotechnology market in North America is being driven by the rising burden of chronic disease and increased expenditure on research and development activities in the U.S. The U.S. is known as the world’s life sciences innovation capital center.
Asia-Pacific region is the fastest growing region in the biotechnology market. Due to increased R&D investment, increased use and availability of biopharmaceuticals for illness and disease treatment, and increased disease diagnosis awareness, the Asia-Pacific region is expected to grow significantly in the future. Furthermore, because the developed markets are somewhat saturated, the Asia-Pacific region represents exceptional potential for venture capitalists and investors.
Some of the prominent players in the global biotechnology market include:
- Lonza
- AstraZeneca
- Pfizer Inc.
- Gilead Sciences Inc.
- F. Hoffmann-La Roche Ltd.
- Biogen
- CELGENE Corporation
- Sanofi
- Abbott
- Novartis AG
Segments Covered in the Report
By Application
- Bio-pharmacy
- Bio-industries
- Bio-services
- Bio-agriculture
- Bio-informatics
By Technology
- Fermentation
- Tissue Engineering and Regeneration
- Polymerase Chain Reaction (PCR) Technology
- Nanobiotechnology
- Chromatography
- Deoxyribonucleic Acid (DNA) Sequencing
- Cell Based Assay
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of the World
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Biotechnology Market
5.1. COVID-19 Landscape: Biotechnology Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Biotechnology Market, By Technology
8.1. Biotechnology Market, by Technology Type, 2021-2030
8.1.1. Fermentation
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Tissue Engineering and Regeneration
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Polymerase Chain Reaction (PCR) Technology
8.1.3.1. Market Revenue and Forecast (2019-2030)
8.1.4. Nanobiotechnology
8.1.4.1. Market Revenue and Forecast (2019-2030)
8.1.5. Chromatography
8.1.5.1. Market Revenue and Forecast (2019-2030)
8.1.6. Deoxyribonucleic Acid (DNA) Sequencing
8.1.6.1. Market Revenue and Forecast (2019-2030)
8.1.7. Cell Based Assay
8.1.7.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Biotechnology Market, By Application
9.1. Biotechnology Market, by Application, 2021-2030
9.1.1. Bio-pharmacy
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Bio-industries
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Bio-services
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Bio-agriculture
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Bio-informatics
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Biotechnology Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Technology (2019-2030)
10.1.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Technology (2019-2030)
10.1.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Technology (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Technology (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Technology (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Technology (2019-2030)
10.5.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Technology (2019-2030)
10.5.3.2. Market Revenue and Forecast, by Application (2019-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Technology (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
Chapter 11. Company Profiles
11.1. Lonza
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. AstraZeneca
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Pfizer Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Gilead Sciences Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. F. Hoffmann-La Roche Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Biogen
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. CELGENE Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Sanofi
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Abbott
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Novartis AG
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1450
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
